38 Advances in MRSA Epidemiology I

Saturday, April 2, 2011: 2:15 PM-4:15 PM
Coronado A (Hilton Anatole)
Type: Abstracts
Moderators:
Matthew Samore, MD and Marin L. Schweizer, PhD

2:15 PM
295
Differences in MRSA Strains from Pediatric and Adult Hospital Patients in Orange County (OC), CA
Lyndsey O. Hudson, MSc, Division of Infectious Disease Epidemiology, Imperial College London; Brian Spratt, PhD, Division of Infectious Disease Epidemiology, Imperial College London; Courtney Reynolds, MS, School of Social Ecology and Division of Infectious Diseases, University of California Irvine School of Medicine; Leah Terpstra, BA, Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine; Adrijana Gombosev, BS, Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine; Paul Hannah, BS, Orange County Public Healthcare Agency; Lydia Mikhail, MBA, Orange County Public Healthcare Agency; Richard Alexander, MPH, Division of Infectious Disease Epidemiology, Imperial College London; Douglas Moore, PhD, Division of Infectious Disease Epidemiology, Imperial College London; Susan S. Huang, MD, MPH, Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine
2:30 PM
296
Risk of methicillin resistant Staphylococcus aureus (MRSA) infection in patients colonized with community-associated (CA) and healthcare-associated (HCA) MRSA
Jo-anne M. Salangsang, MD, MS, University of Pittsburgh Medical Center; Kathleen A. Shutt, MS, University of Pittsburgh; Melissa I. Saul, MS, University of Pittsburgh; Maria M. Brooks, University of Pittsburgh; Lee H. Harrison, MD, University of Pittsburgh; Carlene A. Muto, MD, MS, University of Pittsburgh Medical Center
2:45 PM
297
Risk Factors and Outcomes among Post-partum Women with Staphylococcus aureus Breast Abscesses in the Era of Community-Associated Methicillin Resistance
Westyn Branch-Elliman, MD, Beth Israel Deaconess Medical Center; Toni H. Golen, MD, Beth Israel Deaconess Medical Center; David S. Yassa, MD, Beth Israel Deaconess Medical Center; Howard S. Gold, MD, Beth Israel Deaconess Medical Center; Sharon B. Wright, MD, MPH, Beth Israel Deaconess Medical Center
3:00 PM
298
Estimating excess length of stay (LoS) attributable to MRSA using an instrumental variable approach
Anant Murthy, MSc, Johns Hopkins Bloomberg School of Public Health; Giulia De Angelis, Geneva University Hospitals; Didier Pittet, Geneva University Hospitals; Jacques Schrenzel, Geneva University Hospitals; Ilker Uckay, Geneva University Hospitals; Stephan Harbarth, Geneva University Hospitals
3:15 PM
299
Attributable Mortality after S. aureus Bacteremia
David van Duin, MD, PhD, Cleveland Clinic Foundation; Thomas Fraser, Cleveland Clinic Foundation; Anil Jain, Cleveland Clinic Foundation; Steven Gordon, Cleveland Clinic Foundation; Nabin Shrestha, Cleveland Clinic Foundation
3:30 PM
300
Analysis of MRSA Transmission Dynamics in the Veterans Affairs System
Makoto Jones, MD, University of Utah; Jian Ying, PhD, University of Utah; Tom Greene, PhD, University of Utah School of Medicine; Molly Leecaster, PhD, University of Utah; Benedikt Huttner, MD, University Hospital, Geneva; Jeanmarie Mayer, MD, University of Utah School of Medicine; Michael Rubin, MD, PhD, VA Salt Lake City IDEAS Center; Matthew Samore, MD, VA Salt Lake City IDEAS Center
3:45 PM
301
Utilization of molecular genotyping and geocoding to improve understanding of the transmission dynamics of recently emerging ST239-MRSA-III in Ohio
Shu-Hua Wang, MD, MPH, The Ohio State University Medical Center; Josť Mediavilla, BS, BA, Public Health Research Institute, University of Medicine and Dentistry of New Jersey; Liang King, PhD, University of Mississippi Medical Center; Liang Chen, PhD, Public Health Research Institute, University of Medicine and Dentistry of New Jersey; Yosef Khan, MBBS, MPH, The Ohio State University Medical Center; Lisa Hines, RN, CIC, The Ohio State University Medical Center; Eric Brandt, The Ohio Department of Health Laboratories; Tammy Bannerman, The Ohio Department of Health Laboratories; Armando Hoet, DVM, PhD, The Ohio State University Medical Center; Preeti Pancholi, PhD, The Ohio State University Medical Center; D. Ashley Robinson, PhD, University of Mississippi Medical Center; Barry Kreiswirth, PhD, Public Health Research Institute, University of Medicine and Dentistry of New Jersey; Kurt B. Stevenson, MD, MPH, The Ohio State University Medical Center
4:00 PM
302
Modeling the Spread of Methicillin-Resistant Staphylococcus aureus Throughout Orange County, California
Sarah M. McGlone, MPH, University of Pittsburgh; Susan S. Huang, MD, MPH, Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine; Kim F. Wong, PhD, University of Pittsburgh; S. Levent Yilmaz, PhD, University of Pittsburgh; Yeohan Song, University of Pittsburgh; Taliser R. Avery, BS, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute; Richard Christie, PhD, University of Pittsburgh; Shawn T. Brown, PhD, Pittsburgh Supercomputing Center; Joshua Epstein, PhD, Johns Hopkins University; Stephen Eubank, PhD, Virginia Bioinformatics Institute; Donald S. Burke, MD, University of Pittsburgh; Richard Platt, MD, Harvard Medical School and Harvard Pilgrim Healthcare Institute; Bruce Y. Lee, MD, MBA, University of Pittsburgh